SMAD2 and idiopathic pulmonary fibrosis: Next, we assayed SMAD2 and SMAD3 phosphorylation in control and IPF fibroblasts treated with PRRX1 siRNA, compared to cells transfected with control siRNA, in presence or absence of TGF-β1 (30 min stimulation) (Figure 5E).